https://www.selleckchem.com/pr....oducts/mpp-iodide.ht
itures. Interventions targeting preventing infections could improve the value of durable ventricular assist device support from the societal and hospital perspectives. Neonatal orthotopic heart transplantation was introduced in the 1980s as a treatment for complex congenital heart disease. Progress in single-ventricle palliation and biventricular correction has resulted in a decline in neonatal heart transplant volume. However, limited reports on neonatal heart transplants have demonstrated favorable outcomes. We report the long-term
Like
Comment
Share
